Keywords: InterMune, Esbriet, Pulmonary fibrosis, France, Reimbursement, Pricing

French price regulator authorizes reimbursement of InterMune's Esbriet

Article | 12 September 2012

Print This

USA-based InterMune (Nasdaq: ITMN) says that French regulator the Comite Economique des Produits de Sante (CEPS) has granted reimbursement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in